Daphne Quimi joined Amicus in September 2007 and currently serves as Chief Financial Officer. She brings experience in public accounting and financial reporting. Prior to Amicus, Ms. Quimi served as Director of Consolidations and External Reporting at Bristol-Myers Squibb. She also held roles of increasing responsibility in the finance department at Johnson & Johnson.
Ms. Quimi currently serves on the boards of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) and Century Therapeutics, Inc. (NASDAQ: IPSC). She received a B.S. in Accountancy from Monmouth University and an M.B.A from the Stern School of Business of New York University. She is a certified public accountant in the state of New Jersey.